The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Attentional effects of nicotinic agonists in rats
Abstract
Nicotine can increase stimulus detection, response rate and speed in the five-choice serial reaction time task, a rodent test of attention. In the present experiments, four other nicotinic agonists with different pharmacological profiles were compared in the same procedure. The response profile of epibatidine resembled that previously obtained with nicotine in that response accuracy was enhanced and omission errors and correct response latency decreased. ABT-418 transiently increased accuracy in the first 10 min of test sessions and reduced response latency. Isoarecolone caused a dose-related increase in accuracy, but had no effect on omissions or response latency. This absence of effects on response rate- or speed-related measures may be related to its previously reported reduced ability to release dopamine as compared with nicotine. The alpha7-agonist AR-R17779 was without effect on any measure, indicating that this receptor subtype may not mediate nicotinic effects on attention. Affinity constants of compounds, determined in competition binding assays targeting the alpha4beta2, alpha7, alpha3beta4 and alpha3beta2* nAChR subtypes, could not explain the differential behavioural effects observed. Differences in their functional efficacy at nAChR subtypes may instead be responsible. The finding that attentional performance and response rate and speed can be selectively modulated by nicotinic agonists is encouraging for the development of drugs with therapeutic properties similar to those of nicotine but with reduced unwanted effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pharmacological studies failed to implicate the α7 nAChR in attention.
“Pharmacological studies failed to implicate this receptor in attention (Grottick and Higgins, 2000; Hahn et al, 2003).”
From Modes and models of forebrain cholinergic neuromodulation of cognition (2011) · cites this paper as Hahn et al, 2003
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Carli, M., Robbins, T. W., Evenden, J. L., & Everitt, B. J. (1983) · Behavioural Brain Research · doi:10.1016/0166-4328(83)90138-9 · Cited by 736
Role of dopamine in the behavioural actions of nicotine related to addiction
Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 697
Luetje, C., & Patrick, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-03-00837.1991 · Cited by 558
Lukas, R. J., Changeux, J., Novère, N. G. L., Albuquerque, E. X., Balfour, D. J. K., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B. S., Collins, A. C., et al. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01406-6 · Cited by 536
Self-citationThe effects of nicotine on locomotor activity in non‐tolerant and tolerant rats
Clarke, P. B. S., & Kumar, R. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb09398.x · Cited by 457
Nicotine effects on adults with attention-deficit/hyperactivity disorder
Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., Rose, J. E., & March, J. (1996) · Psychopharmacology · doi:10.1007/bf02246281 · Cited by 415
Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · PubMed · Cited by 392
Assembly of Human Neuronal Nicotinic Receptor α5 Subunits with α3, β2, and β4 Subunits
Wang, F., Gerzanich, V., Wells, G. B., Anand, R., Peng, X.-D., Keyser, K. T., & Lindstrom, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17656 · Cited by 345
Nicotine-Haloperidol Interactions and Cognitive Performance in Schizophrenics
Levin, E. D. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00018-8 · Cited by 338
Transdermal nicotine effects on attention
Levin, E. D., Conners, C. K., Silva, D., Hinton, S. C., Meck, W. H., March, J. S., & Rose, J. E. (1998) · Psychopharmacology · doi:10.1007/s002130050750 · Cited by 331
Cole, B. J., & Robbins, T. W. (1989) · Behavioural Brain Research · doi:10.1016/s0166-4328(89)80048-8 · Cited by 321
Intravenous nicotine in Alzheimer's disease: a pilot study
NEWHOUSE, P. A., Sunderland, T., Tariot, P. N., Blumhardt, C. L., Weingartner, H., Mellow, A. M., & Murphy, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00174504 · Cited by 308
Gerzanich, V., Peng, X.-D., Wang, F., Wells, G. B., Anand, R., Fletcher, S. R., & Lindstrom, J. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10533-6 · Cited by 290
Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit
Papke, R. L., & Heinemann, S. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09896-7 · Cited by 259
Davies, A. R. L., HARDICK, D. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., & Wonnacott, S. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00221-4 · Cited by 246
Self-citationGrottick, A. J., & Higgins, G. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00305-3 · Cited by 240
Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers
Foulds, J., Stapleton, J., Swettenham, J., Bell, N., McSorley, K., & Russell, M. A. (1996) · Psychopharmacology · doi:10.1007/bf02805972 · Cited by 228
Peng, X.-D., Katz, M., Gerzanich, V., Anand, R., & Lindström, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10029-1 · Cited by 222
Everitt, B. J., Robbins, T. W., & Muir, J. L. (1995) · Psychopharmacology · doi:10.1007/bf02245253 · Cited by 214
AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats
Levin, E. D., Bettegowda, C., Blosser, J. C., & Gordon, J. C. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199911000-00014 · Cited by 193
Lukas, R. J., Norman, S. A., & Lucero, L. M. (1993) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1993.1001 · Cited by 192
Hahn, B., Shoaib, M., & Stolerman, I. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1005-6 · Cited by 188
Self-citationNicotine enhances sustained attention in the rat under specific task conditions
Mirza, N. R., & Stolerman, I. P. (1998) · Psychopharmacology · doi:10.1007/s002130050671 · Cited by 181
Self-citationDecker, M. W., Brioni, J. D., Sullivan, J. P., Buckley, M. J., Radek, R. J., Raszkiewicz, J. L., Kang, C. H., Kim, D. J., Giardina, W. J., & Wasicak, J. T. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22339-4 · Cited by 180
Sullivan, J. P., Decker, M. W., Brioni, J. D., Donnelly‐Roberts, D. L., Anderson, D. J., Bannon, A. W., Kang, C. H., Adams, P., Piattoni-Kaplan, M., & Buckley, M. J. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23809-5 · Cited by 168
Sharples, C. G. V., Kaiser, S., Soliakov, L. S., Marks, M. J., Collins, A. C., Washburn, M. S., Wright, E., Spencer, J. A., Gallagher, T., Whiteaker, P., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02783.2000 · Cited by 164
Self-citationBaunez, C., & Robbins, T. W. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00065-2 · Cited by 161
Sharples, C. G. V., & Wonnacott, S. (2001) · Cited by 141
Self-citationBlondel, A., Sanger, D. J., & Moser, P. C. (2000) · Psychopharmacology · doi:10.1007/s002130000378 · Cited by 138
MULLEN, G. B., Napier, J. J., Balestra, M., DeCory, T. R., Hale, G., Macor, J. E., Mack, R. A., Loch, J. T., Wu, E. X., Kover, A., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000249r · Cited by 130
Lewis, T., Harkness, P. C., Sivilotti, L. G., Colquhoun, D., & Millar, N. S. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.299bb.x · Cited by 107
The Cognitive Psychopharmacology of Alzheimer's Disease: Focus on Cholinergic Systems
Lawrence, A. D., & Sahakian, B. J. (1998) · Neurochemical Research · doi:10.1023/a:1022419712453 · Cited by 105
Buccafusco, J. J., Jackson, W. J., Terry, A. V., Marsh, K. C., Decker, M. W., & Arnerić, S. P. (1995) · Psychopharmacology · doi:10.1007/bf02311172 · Cited by 100
Prendergast, M., Jackson, W. J., Terry, A. V., Decker, M. W., Arnerić, S. P., & Buccafusco, J. J. (1998) · Psychopharmacology · doi:10.1007/s002130050538 · Cited by 99
Pharmacological effects of epibatidine optical enantiomers
Damaj, M. I., Creasy, K. R., Grove, A. D., et al. (1994) · Brain Research · doi:10.1016/0006-8993(94)91950-x · Cited by 97
(S)‐3‐メチル‐5‐(1‐メチル‐2‐ピロリジニル)イソキサゾール(ART418) 認知促進および抗不安活性を持つ新しいコリン作動性リガンド II in vivoの性質
Decker, M. W., Brioni, J. D., Sullivan, J. P., et al. (1994) · Journal of Pharmacology and Experimental Therapeutics · Cited by 92
Nicotine-induced Attentional Enhancement in Rats Effects of Chronic Exposure to Nicotine
Hahn, B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00348-2 · Cited by 78
Self-citationLocomotor activation and dopamine release produced by nicotine and isoarecolone in rats
Whiteaker, P., Garcha, H. S., Wonnacott, S., & Stolerman, I. P. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16417.x · Cited by 66
Self-citationRidley, D. L., Rogers, A. T., & Wonnacott, S. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704207 · Cited by 58
Self-citationActivation and inhibition of rat neuronal nicotinic receptors by ABT‐418
Papke, R. L., Thinschmidt, J. S., Moulton, B., Meyer, E. M., & Poirier, A. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700930 · Cited by 55
Sharples, C. G. V., Karig, G., Simpson, G. L., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020814l · Cited by 52
Self-citationArnerić, S. P., Anderson, D. J., Bannon, A. W., Briggs, C. A., Buccafusco, J. J., Brioni, J. D., Cannon, J. B., Decker, M. W., Donnelly‐Roberts, D. L., Gopalakrishnan, M., et al. (1995) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1995.tb00274.x · Cited by 40
Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement
Hahn, B., Shoaib, M., & Stolerman, I. P. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200212000-00003 · Cited by 32
Self-citationGrottick, A. J., Wyler, R., & Higgins, G. A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00639-6 · Cited by 26
Tani, Y., Saito, K., Tsuneyoshi, A., Imoto, M., & Ohno, T. (1997) · Psychopharmacology · doi:10.1007/s002130050184 · Cited by 25
Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist
Damaj, M. I., Creasy, K. R., Welch, S. P., Rosecrans, J. A., Aceto, M. D. G., & Martin, B. R. (1995) · Psychopharmacology · doi:10.1007/bf02245822 · Cited by 23
Mirza, N. R., Pei, Q., Stolerman, I. P., et al. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00749-0 · Cited by 23
Self-citationBuccafusco, J. J., Jackson, W. J., Gattu, M., et al. (1995) · Neuroreport · doi:10.1097/00001756-199505300-00037 · Cited by 19
Flagged first, then by citations
Research works printed but not linked: 3
- Arneric, 1994, (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization, J. Pharmacol. Exp. Ther., 270, 310
- Blondel, 1999, Characterisation of the receptor subtypes mediating the effects of nicotine in the 5-choice serial reaction time task, J. Psychopharmacol., 13, A50
- Hahn, 2001, Attentional effects of nicotinic agonists in rats, Soc. Neurosci. Abstr., 27, 313
Cited by
Sorted by citations
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282
Levin, E. D., McClernon, F. J., & Rezvani, A. H. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0164-7 · Cited by 820
Modes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.008 · Cited by 233
Nicotine Enhances Visuospatial Attention by Deactivating Areas of the Resting Brain Default Network
Hahn, B., Ross, T. J., Yang, Y., Kim, I., Huestis, M. A., & Stein, E. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5129-06.2007 · Cited by 199
Self-citationNicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention
Guillem, K., Bloem, B., Poorthuis, R. B., Loos, M., Smit, A. B., Maskos, U., Spijker, S., & Mansvelder, H. D. (2011) · Science · doi:10.1126/science.1207079 · Cited by 191
Wilens, T. E., & Decker, M. W. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.002 · Cited by 164
Hoyle, E., Genn, R. F., Fernandes, C., & Stolerman, I. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0549-2 · Cited by 161
Self-citationHowe, W. M., Ji, J., Parikh, V., Williams, S., Mocaër, E., Trocmé-Thibierge, C., & Sarter, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.9 · Cited by 150
Parikh, V., Ji, J., Decker, M. W., & Sarter, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5712-09.2010 · Cited by 133
Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129
Smoking impacts on prefrontal attentional network function in young adult brains
Musso, F., Bettermann, F., Vucurevic, G., Stoeter, P., Konrad, A., & Winterer, G. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0499-8 · Cited by 93
Leveraging the cortical cholinergic system to enhance attention
Demeter, E., & Sarter, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.060 · Cited by 75
Young, J. W., Meves, J. M., & Geyer, M. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.028 · Cited by 69
NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release
Zmarowski, A., Sarter, M., & Bruno, J. P. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04333.x · Cited by 52
Metadata
- Authors
- Hahn, B., Sharples, C. G. V., Wonnacott, S., Shoaib, M., & Stolerman, I. P.
- Affiliations
- King's College London (GB)
- University of Bath (GB)
- Corresponding author
- Hahn, Britta
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 44
- Issue
- 8
- Pages
- 1054-1067
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2070283278
- Cited by
- 135
- References
- 49
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 11 · 2012: 11
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotinic agonists, attention, 5-choice serial reaction time task, epibatidine, ABT-418, alpha7 nicotinic acetylcholine receptor, α4β2 nicotinic acetylcholine receptor, α3β4 nicotinic acetylcholine receptor, nAChR subtypes, response latency, response accuracy, omission errors, dopamine release, nicotine
- MeSH terms
- Animals, Arecoline, Attention, Binding, Competitive, Brain, Bridged-Ring Compounds, Cell Line, Isoxazoles, Male, Photic Stimulation, Pyridines, Pyrrolidines, Radioligand Assay, Spiro Compounds, Nicotinic Agonists, Bridged Bicyclo Compounds, Heterocyclic, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
